Navigating the Salesforce–Veeva CRM Split: A Strategic Guide for Pharmaceutical Companies

June 20, 2025   |    Category: Life Sciences

Apptad

Navigating the Salesforce–Veeva CRM Split: A Strategic Guide for Pharmaceutical Companies

The pharmaceutical industry is undergoing a major CRM transformation. With Veeva Systems officially ending its reliance on Salesforce’s platform by September 2025, life sciences companies must now choose between two divergent paths: migrate to Veeva Vault CRM or remain with Salesforce and rebuild their CRM stack. This decision will have long-term implications for commercial operations, compliance, and digital transformation strategies.


Why the Split Matters

For over a decade, Veeva CRM—built on Salesforce—was the gold standard for pharmaceutical sales and marketing teams. It offered a tailored solution for managing HCP (healthcare professional) relationships, compliant content delivery, and field force effectiveness. However, Veeva’s move to its own Vault platform signals a shift toward vertical integration and greater control over innovation.

Key Drivers Behind the Split:

  • Platform Independence: Veeva wants to innovate at its own pace without being tied to Salesforce’s release cycles.
  • Cost Optimization: Veeva paid Salesforce hundreds of millions annually in licensing fees.
  • Unified Ecosystem: Vault CRM integrates natively with Veeva’s regulatory, clinical, and quality platforms.
  • Security and Compliance: Veeva can now offer end-to-end compliance and data governance under one roof.

Platform Deep Dive: Veeva Vault CRM vs. Salesforce

Veeva Vault CRM

Strengths:

  • Purpose-built for life sciences with pre-configured modules for medical, commercial, and regulatory teams.
  • Integrated ecosystem enabling seamless data flow between CRM, content management, and clinical systems.
  • Compliance-first architecture built to meet FDA, EMA, and HIPAA standards.
  • Modern UI/UX designed for mobile-first field reps and intuitive workflows.

Challenges:

  • New platform maturity may mean fewer third-party integrations.
  • Migration complexity requires careful planning and execution.
  • Training needs for staff unfamiliar with Vault’s interface and backend.

Salesforce Health Cloud (Post-Veeva)

Strengths:

  • Proven scalability and trusted by Fortune 500 companies across industries.
  • Advanced AI and analytics capabilities through Einstein AI and Tableau.
  • Highly customizable for bespoke workflows and integrations.
  • Large ecosystem of third-party apps and partners.

Challenges:

  • Less tailored for life sciences, requiring custom development.
  • Loss of Veeva-specific modules like CLM and Approved Email.
  • Greater responsibility on IT teams to ensure regulatory compliance.

Risks of Inaction

Failing to act before the September 2025 deadline could expose companies to:

  • Security vulnerabilities: Unsupported platforms are prime targets for cyberattacks.
  • Compliance gaps: Outdated systems may fall short of evolving regulatory standards.
  • Operational disruptions: CRM downtime can cripple sales force effectiveness and HCP engagement.
  • Data integrity issues: Poorly managed migrations risk data loss or corruption.

Best Practices for a Successful Transition

1. Conduct a Strategic Assessment

  • Map your CRM architecture, including systems, data flows, and integrations.
  • Evaluate business processes across sales, medical affairs, marketing, and compliance.
  • Identify future needs such as market expansion, new product launches, or digital engagement strategies.

2. Choose the Right Platform for Your Business Model

  • Assess platform alignment with your operational and strategic goals.
  • Consider long-term scalability and how each platform supports future growth.
  • Evaluate total cost of ownership, including licensing, customization, training, and support.

3. Plan a Phased Migration

  • Start with pilot programs to test the new CRM in a controlled environment.
  • Use agile methodologies to break the migration into manageable sprints.
  • Monitor performance metrics like user adoption, data accuracy, and system uptime.

4. Invest in Change Management

  • Communicate the transition plan clearly to all stakeholders.
  • Develop tailored training programs for different roles within the organization.
  • Create feedback channels to gather user input and improve system adoption.

5. Ensure Data Integrity and Compliance

  • Conduct data audits to clean and validate existing records.
  • Use automated tools for secure and accurate data migration.
  • Validate post-migration data and engage compliance teams to ensure regulatory readiness.

6. Leverage External Expertise

  • Hire consultants with experience in CRM transitions for life sciences.
  • Use system integrators to connect CRM with other enterprise platforms.
  • Tap into vendor support resources from Veeva and Salesforce to accelerate implementation.

Final Thoughts

The Salesforce–Veeva CRM split is more than a technical migration—it’s a strategic pivot. Companies that act decisively can modernize their commercial operations, improve HCP engagement, and future-proof their digital infrastructure. Whether you choose Veeva Vault for its life sciences specialization or Salesforce for its scalability and innovation, the key lies in proactive planning and execution.











    Ready to Transform Your Business?

    Connect with Us